World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
46
Citations
8059
World Ranking
4623
National Ranking
2082

Igor M. Belyakov publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Igor M. Belyakov sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 90 publications — 1st percentile

1% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Igor M. Belyakov D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Igor M. Belyakov sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 46 D-Index — 8th percentile

8% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Igor M. Belyakov is affiliated with the University of Michigan-Ann Arbor in the United States. Their research spans several fields primarily within medicine and biochemistry, genetics, and molecular biology. The scientist's work encompasses subfields such as biotechnology, infectious diseases, emergency medicine, molecular biology, and management of technology and innovation.

Their publication record includes research on SARS-CoV-2 and COVID-19, studies on intramuscular injections and their effects, microbial inactivation methods, transgenic plants and applications, viral infectious diseases and gene expression in insects, economic and technological systems analysis, and Arctic and Russian policy studies.

Frequent publication venues for their work include:

  • Expert Review of Vaccines
  • Public Administration Issues
  • UNC Libraries
  • Molecular Biology
  • PubMed

The scientist has collaborated frequently with several coauthors, such as:

  • D. N. Kisakov
  • E. V. Tigeeva
  • Л. И. Карпенко
  • L.A. Kisakova
  • M. B. Borgoyakova

Notable papers authored or coauthored by Igor M. Belyakov include:

  • "The use of electroporation to deliver DNA-based vaccines," 2023, Expert Review of Vaccines
  • "ON QUANTITATIVE RISK ASSESSMENT OF INFRASTRUCTURAL PROJECTS WITH STATE PARTICIPATION," 2022, Public Administration Issues
  • "Large intestine-targeted, nanoparticle-releasing oral vaccine to control genitorectal viral infection," 2020, UNC Libraries
  • "Immunization of Mice with the pVAXrbd DNA Vaccine by Jet Injection Induces a Stronger Immune Response and Protection against SARS-CoV-2 Compared to Intramuscular Injection by Syringe," 2025, Molecular Biology
  • "[Immunization of Mice with the pVAXrbd DNA Vaccine by Jet Injection Induces a Stronger Immune Response and Protection against SARS-CoV-2 Compared to Intramuscular Injection by Syringe].," 2025, PubMed

Best Publications

  • Strategies for designing and optimizing new generation vaccines

    Jay A. Berzofsky;Jeffrey D. Ahlers;Igor M. Belyakov

  • Progress on new vaccine strategies for the immunotherapy and prevention of cancer

    Jay A. Berzofsky;Masaki Terabe;Sang Kon Oh;Igor M. Belyakov

  • Mucosal immunization with HIV-1 peptide vaccine induces mucosal and systemic cytotoxic T lymphocytes and protective immunity in mice against intrarectal recombinant HIV-vaccinia challenge

    Igor M. Belyakov;Michael A. Derby;Jeffrey D. Ahlers;Brian L. Kelsall

  • Shared modes of protection against poxvirus infection by attenuated and conventional smallpox vaccine viruses

    Igor M. Belyakov;Patricia Earl;Amiran Dzutsev;Vladimir A. Kuznetsov

  • Transcutaneous immunization induces mucosal CTLs and protective immunity by migration of primed skin dendritic cells

    Igor M. Belyakov;Scott A. Hammond;Jeffrey D. Ahlers;Gregory M. Glenn

  • Mucosal AIDS vaccine reduces disease and viral load in gut reservoir and blood after mucosal infection of macaques.

    Igor M. Belyakov;Zdenek Hel;Brian Kelsall;Vladimir A. Kuznetsov

  • What Role Does the Route of Immunization Play in the Generation of Protective Immunity against Mucosal Pathogens?

    Unknown

  • The importance of local mucosal HIV-specific CD8(+) cytotoxic T lymphocytes for resistance to mucosal viral transmission in mice and enhancement of resistance by local administration of IL-12.

    Igor M. Belyakov;Jeffrey D. Ahlers;Benjamin Y. Brandwein;Patricia Earl

  • Mucosal vaccination overcomes the barrier to recombinant vaccinia immunization caused by preexisting poxvirus immunity

    Igor M. Belyakov;Bernard Moss;Warren Strober;Jay A. Berzofsky

  • Progress on new vaccine strategies against chronic viral infections

    Jay A. Berzofsky;Jeffrey D. Ahlers;John Edward Janik;John Morris

  • Toll-like receptor ligands synergize through distinct dendritic cell pathways to induce T cell responses: Implications for vaccines

    Qing Zhu;Colt Egelston;Aravindhan Vivekanandhan;Satoshi Uematsu

  • Using 3 TLR ligands as a combination adjuvant induces qualitative changes in T cell responses needed for antiviral protection in mice.

    Qing Zhu;Colt Egelston;Susan Gagnon;Yongjun Sui

  • Large intestine-targeted, nanoparticle-releasing oral vaccine to control genitorectal viral infection

    Qing Zhu;James Talton;Guofeng Zhang;Tshaka Cunningham

  • Immunobiology of mucosal HIV infection and the basis for development of a new generation of mucosal AIDS vaccines.

    Igor M. Belyakov;Jay A. Berzofsky

  • DNA vaccines encoding human immunodeficiency virus-1 glycoprotein 120 fusions with proinflammatory chemoattractants induce systemic and mucosal immune responses.

    Arya Biragyn;Igor M. Belyakov;Yen Hung Chow;Dimiter S. Dimitrov

  • Induction of a Mucosal Cytotoxic T-Lymphocyte Response by Intrarectal Immunization with a Replication-Deficient Recombinant Vaccinia Virus Expressing Human Immunodeficiency Virus 89.6 Envelope Protein

    Igor M. Belyakov;Linda S. Wyatt;Jeffrey D. Ahlers;Patricia Earl

  • Impact of vaccine-induced mucosal high-avidity CD8+CTLs in delay of AIDS viral dissemination from mucosa

    Igor M. Belyakov;Vladimir A. Kuznetsov;Brian Kelsall;Dennis Klinman

  • A push–pull approach to maximize vaccine efficacy: Abrogating suppression with an IL-13 inhibitor while augmenting help with granulocyte/macrophage colony-stimulating factor and CD40L

    Jeffrey D. Ahlers;Igor M. Belyakov;Masaki Terabe;Rima Koka

  • Immunostimulatory DNA-Based Vaccines Elicit Multifaceted Immune Responses Against HIV at Systemic and Mucosal Sites

    Anthony A. Horner;Sandip K. Datta;Kenji Takabayashi;Igor M. Belyakov

  • Memories that last forever: strategies for optimizing vaccine T-cell memory

    Unknown

  • A novel functional CTL avidity/activity compartmentalization to the site of mucosal immunization contributes to protection of macaques against simian/human immunodeficiency viral depletion of mucosal CD4+ T cells.

    Igor M. Belyakov;Dmitry Isakov;Qing Zhu;Amiran Dzutsev

  • Approaches to improve engineered vaccines for human immunodeficiency virus and other viruses that cause chronic infections

    Berzofsky Ja;Ahlers Jd;Derby Ma;Pendleton Cd

Frequent Co-Authors

Jay A. Berzofsky
Jay A. Berzofsky National Institutes of Health
Warren Strober
Warren Strober National Institute of Allergy and Infectious Diseases
Brian L. Kelsall
Brian L. Kelsall National Institute of Allergy and Infectious Diseases
Genoveffa Franchini
Genoveffa Franchini National Institutes of Health
Bernard Moss
Bernard Moss National Institutes of Health
Masaki Terabe
Masaki Terabe National Institutes of Health
David H. Margulies
David H. Margulies National Institutes of Health
Alexander Bukreyev
Alexander Bukreyev The University of Texas Medical Branch at Galveston
Ranajit Pal
Ranajit Pal Advanced Bioscience Laboratories (United States)
David Venzon
David Venzon National Institutes of Health

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in expanding their expertise beyond Immunology, exploring related healthcare degrees can open new career opportunities. Accelerated nursing programs, such as absn programs with high acceptance rates, offer a fast track to becoming a registered nurse. These programs are ideal for individuals seeking a quicker path without compromising quality education.

LPN programs are another accessible pathway into nursing, providing foundational skills that are essential in many healthcare settings. You can find accredited lpn programs easy to get into designed to support students through a smooth admission process and comprehensive training.

For those aiming to advance further, nurse practitioner programs provide the credentials needed to deliver specialized care. Many institutions now offer nurse practitioner programs with easy admission, making it easier to pursue an advanced practice role with flexibility and support.

Specifically, for those interested in mental health, top online pmhnp programs combine convenience with excellent clinical placement rates, preparing students for impactful careers as psychiatric-mental health nurse practitioners.

Best Scientists Citing Igor M. Belyakov

Recently Published Articles